HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypothermia prevents biphasic glutamate release and corresponding neuronal degeneration after transient spinal cord ischemia in the rat.

Abstract
1. Spinal cord ischemia evoked a biphasic increase in CSF-Glu during 20 min of ischemia (40%) and at 2 hr after reperfusion (70%) in the nontreated group that was attenuated by all treated groups. But MK-801 (15 micrograms i.t.) did not affect the increased Glu at 2 hr (80%). 2. The argyrophilia observed in laminae II-V at 8 hr after reperfusion was attenuated by hypothermia (33 degrees C) and combination with MK-801, but the attenuation was less with MK-801. 3. Mild hypothermia attenuated the biphasic increase in CSF-Glu and corresponding development of neuronal damage after spinal cord ischemia. 4. Mild hypothermia with NMDA antagonism did not yield any further effects, suggesting that hypothermia itself plays a pivotal role in the protection.
AuthorsT Ishikawa, M Marsala
JournalCellular and molecular neurobiology (Cell Mol Neurobiol) Vol. 19 Issue 2 Pg. 199-208 (Apr 1999) ISSN: 0272-4340 [Print] United States
PMID10081604 (Publication Type: Journal Article)
Chemical References
  • Excitatory Amino Acid Antagonists
  • Receptors, N-Methyl-D-Aspartate
  • Glutamic Acid
  • Dizocilpine Maleate
Topics
  • Animals
  • Combined Modality Therapy
  • Denervation
  • Dizocilpine Maleate (pharmacology)
  • Excitatory Amino Acid Antagonists (pharmacology)
  • Glutamic Acid (cerebrospinal fluid, metabolism)
  • Hypothermia, Induced
  • Injections, Spinal
  • Male
  • Microdialysis
  • Nerve Degeneration (drug therapy, physiopathology, prevention & control)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate (physiology)
  • Reperfusion Injury (drug therapy, physiopathology)
  • Spinal Cord (blood supply, chemistry, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: